Abstract
Pneumoperitoneum, necessitates surgical intervention in 85-90% of cases, relies heavily on CT scans for diagnosis. Delay or misdiagnosis in detecting pneumoperitoneum can significantly increase mortality and morbidity. Our study introduced PACT-3D, a deep learning model developed to identify pneumoperitoneum in CT images. In this single hospital study, we retrospectively reviewed abdominal CT scans from January 2012 to December 2021, excluded CT of image acquisition error and without reports to form the development dataset for training the model. We evaluated the PACT- 3D model using a simulated test set of 14,039 scans and a prospective test set of 6,351 scans, collected from December 2022 to May 2023 at the same center. PACT-3D achieved a sensitivity of 0.81 and a specificity of 0.99 in retrospective testing, with prospective validation yielding a sensitivity of 0.83 and a specificity of 0.99. Sensitivity improved to 0.95 and 0.98 when excluding cases with a small amount of free air (total volume < 10ml) in simulated and prospective test sets, respectively. By delivering accurate and consistent patient-level predictions and providing segmented masks, PACT- 3D holds significant potential for assisting rapid decision-making in emergency care, thereby potentially improving patient outcomes.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study received approval from the Institutional Review Board of Far Eastern Memorial Hospital (FEMH 111086-F).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are not available for public use
